Efficacy of Propofol vs Placebo in the Prevention of Coughing During

Status Completed

Clinical Trial Summary

Emergence of general anesthesia is a critical period, in the same way as the induction of anesthesia, during which several adverse events may occur. Extubation may even be more difficult than the intubation, with a higher respiratory complications rate. Among these, cough is common and expected. It can be associated with significant complications including hypertension, tachycardia, increased intracranial pressure, bleeding at the surgical site or even wound dehiscence.

The incidence of coughing during emergence of general anesthesia varies depending on the type of airway instrumentation, the population under study, agents used for the maintenance of the anesthesia and techniques used to prevent coughing. In the literature, the incidence of coughing during emergence of general anesthesia under endotracheal intubation varies from 38 to 96%. In our center, the incidence of coughing during emergence of general anesthesia under desflurane and endotracheal intubation is 30 % according to a local preliminary study.

Propofol is well-known to inhibit airway reflexes. Total intravenous anesthesia (TIVA) is associated with a lower incidence of coughing compared to inhalated anesthesia. The efficacy of propofol at a subhypnotic dose to reduce coughing during emergence has recently been demonstrated in patients undergoing nasal surgery under sevoflurane. However, the most effective antitussive dose remains unknown and its efficacy during anesthesia under desflurane has not yet been demonstrated.

Propofol is rapidly available, simple to administer and has an interesting pharmacological profile, among others due to its short half-life.

The aim of this study is to evaluate if an intravenous bolus of 0.5 mg/kg of propofol is more effective than placebo administration to decrease the incidence of coughing during emergence of general anesthesia under desflurane (PROPOREV). Propofol could also reduce the incidence of postoperative nausea and vomiting (PONV).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02932397
Study type	Interventional
Source	Centre hospitalier de l'Université de Montréal (CHUM)
Contact
Status	Completed
Phase	N/A
Start date	October 2016
Completion date	December 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04361799` - Perioperative Closed-loop Glucose Control	N/A
Completed	`NCT01193972` - Decision Aid Development for Smokers	Phase 1
Completed	`NCT00966186` - The Rotational Insertion Technique for ProSeal Laryngeal Mask Airway	N/A
Completed	`NCT00795392` - Preoperative Psychological Evaluation as Predictor of Outcomes	N/A
Completed	`NCT01856998` - Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery	Phase 3
Not yet recruiting	`NCT06344325` - ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia	Phase 4
Completed	`NCT03857750` - Neuromuscular Blocking Agents in the Elderly
Completed	`NCT00875134` - Testing of the Apnea Prevention Device	Phase 1/Phase 2
Completed	`NCT00290108` - The Influence of Injection Rate on EEG Propofol Peak Effect as Measured by Bispectral Index	N/A
Completed	`NCT04020887` - Telemedicine Control Tower for the Post-Anesthesia Care Unit	N/A
Not yet recruiting	`NCT06039306` - Perioperative Immunonutrition Under Enhanced Recovery After Surgery	N/A
Completed	`NCT00948597` - Development of PK/PD Model for Individualized Propofol Dosing	N/A
Completed	`NCT00776880` - Does American Society of Anesthesiologists (ASA) Physical Status Scale Enough in Patients Assessment	N/A
Completed	`NCT04089592` - Comparison Of Dexmedetomidine and Fentanyl In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy.	N/A
Not yet recruiting	`NCT03593252` - Bowel Preparation in Elective Pediatric Colorectal Surgery	N/A
Not yet recruiting	`NCT04225702` - Effect Of Aspirin Preoperative on Postoperative Cognitive Dysfunction In Elderly Patients Undergoing Knee Arthroplasty
Recruiting	`NCT05647252` - General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery	Phase 3
Completed	`NCT00205244` - Preoperative Preparation for Children	N/A
Completed	`NCT05392452` - Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)	N/A
Completed	`NCT03455413` - Quality of Perioperative Invasive Ventilation in PICU

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficacy of Propofol vs Placebo in the Prevention of Coughing During Emergence of General Anesthesia Under Desflurane — PROPOREV

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms